FI874596A0 - Peptidpreparat. - Google Patents

Peptidpreparat.

Info

Publication number
FI874596A0
FI874596A0 FI874596A FI874596A FI874596A0 FI 874596 A0 FI874596 A0 FI 874596A0 FI 874596 A FI874596 A FI 874596A FI 874596 A FI874596 A FI 874596A FI 874596 A0 FI874596 A0 FI 874596A0
Authority
FI
Finland
Prior art keywords
peptidpreparat
Prior art date
Application number
FI874596A
Other languages
English (en)
Other versions
FI86254B (fi
FI86254C (fi
FI874596A (fi
Inventor
Klavs Holger Joergensen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK503386A external-priority patent/DK503386D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of FI874596A0 publication Critical patent/FI874596A0/fi
Publication of FI874596A publication Critical patent/FI874596A/fi
Publication of FI86254B publication Critical patent/FI86254B/fi
Application granted granted Critical
Publication of FI86254C publication Critical patent/FI86254C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FI874596A 1986-10-20 1987-10-19 Foerfarande foer framstaellning av insulinpreparat. FI86254C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK503386 1986-10-20
DK503386A DK503386D0 (da) 1986-10-20 1986-10-20 Peptidpraeparater
DK356987A DK356987D0 (fi) 1987-07-10 1987-07-10
DK356987 1987-07-10

Publications (4)

Publication Number Publication Date
FI874596A0 true FI874596A0 (fi) 1987-10-19
FI874596A FI874596A (fi) 1988-04-21
FI86254B FI86254B (fi) 1992-04-30
FI86254C FI86254C (fi) 1992-08-10

Family

ID=26067111

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874596A FI86254C (fi) 1986-10-20 1987-10-19 Foerfarande foer framstaellning av insulinpreparat.

Country Status (18)

Country Link
US (1) US5070186A (fi)
EP (1) EP0265213B1 (fi)
KR (1) KR880004819A (fi)
CN (1) CN87107049A (fi)
AU (1) AU616381B2 (fi)
CA (1) CA1316819C (fi)
DE (1) DE3778287D1 (fi)
ES (1) ES2033871T3 (fi)
FI (1) FI86254C (fi)
GR (1) GR3004912T3 (fi)
HU (1) HU201475B (fi)
IE (1) IE60264B1 (fi)
IL (1) IL84203A (fi)
NO (1) NO170754C (fi)
NZ (1) NZ222214A (fi)
PH (1) PH23446A (fi)
PT (1) PT85949B (fi)
YU (1) YU46665B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
ATE290877T1 (de) * 1998-01-09 2005-04-15 Novo Nordisk As Stabilisierte insulin-zubereitungen
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
WO2003017915A1 (en) * 2001-08-27 2003-03-06 Novo Nordisk A/S A cartridge and a medical delivery system accommodating such a cartridge
US9376479B2 (en) * 2002-12-31 2016-06-28 Anjinomoto Althea, Inc. Human growth hormone crystals and methods for preparing them
BR0317896A (pt) * 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Complexos de cristais de proteìna e polìmeros iÈnicos
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
ES2542146T3 (es) 2006-07-31 2015-07-31 Novo Nordisk A/S Insulinas extendidas PEGiladas.
WO2008034881A1 (en) 2006-09-22 2008-03-27 Novo Nordisk A/S Protease resistant insulin analogues
US9387176B2 (en) 2007-04-30 2016-07-12 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
EP2152243A2 (en) * 2007-04-30 2010-02-17 Novo Nordisk A/S Highly concentrated insulin solutions and compositions
ES2618073T3 (es) 2008-03-14 2017-06-20 Novo Nordisk A/S Análogos de insulina estabilizados frente a proteasas
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
WO2010043566A2 (de) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Kombination von einem insulin und einem glp-1-agonisten
PT2554183T (pt) 2009-11-13 2018-07-09 Sanofi Aventis Deutschland Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina
PL3345593T3 (pl) 2009-11-13 2024-04-08 Sanofi-Aventis Deutschland Gmbh Kompozycja farmaceutyczna zawierająca desPro36-eksendynę-4(1-39)-Lys6-NH2 i metioninę
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
US8637458B2 (en) * 2010-05-12 2014-01-28 Biodel Inc. Insulin with a stable basal release profile
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
SI2611458T1 (sl) 2010-08-30 2017-01-31 Sanofi-Aventis Deutschland Gmbh Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CA2846413C (en) 2011-08-29 2021-11-02 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
CN104364260B (zh) 2012-04-11 2017-02-22 诺和诺德股份有限公司 胰岛素制剂
US9399065B2 (en) 2012-04-16 2016-07-26 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
WO2014161837A1 (en) 2013-04-03 2014-10-09 Sanofi Treatment of diabetes mellitus by long–acting formulations of insulins
US9896496B2 (en) 2013-10-07 2018-02-20 Novo Nordisk A/S Derivative of an insulin analogue
JP6970615B2 (ja) 2014-12-12 2021-11-24 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング インスリングラルギン/リキシセナチド固定比処方
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
RS62295B1 (sr) 2016-12-16 2021-09-30 Novo Nordisk As Farmaceutskе kompozicijе kojе sadržе insulin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2076082A (en) * 1935-04-08 1937-04-06 Nordisk Insulinlab Therapeutic product and process
US2179384A (en) * 1937-04-05 1939-11-07 Univ Alberta Therapeutic composition and process of making it
US2190134A (en) * 1939-06-09 1940-02-13 Norton Co Grinding machine
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2801953A (en) * 1952-02-28 1957-08-06 Hoechst Ag Process of preparing crystallized insulin preparations
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
GB1426061A (en) * 1972-12-28 1976-02-25 Ici Ltd Polypeptides
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production

Also Published As

Publication number Publication date
GR3004912T3 (fi) 1993-04-28
NO170754B (no) 1992-08-24
IE60264B1 (en) 1994-06-29
ES2033871T3 (es) 1993-04-01
FI86254B (fi) 1992-04-30
NO874347D0 (no) 1987-10-19
HUT46232A (en) 1988-10-28
PH23446A (en) 1989-08-07
PT85949A (en) 1987-11-01
AU616381B2 (en) 1991-10-31
EP0265213A2 (en) 1988-04-27
YU46665B (sh) 1994-01-20
AU7990787A (en) 1988-04-21
US5070186A (en) 1991-12-03
FI86254C (fi) 1992-08-10
NO874347L (no) 1988-04-21
CA1316819C (en) 1993-04-27
CN87107049A (zh) 1988-07-06
IE872799L (en) 1988-04-20
KR880004819A (ko) 1988-06-27
DE3778287D1 (de) 1992-05-21
EP0265213A3 (en) 1988-11-09
HU201475B (en) 1990-11-28
EP0265213B1 (en) 1992-04-15
YU191887A (en) 1989-04-30
NO170754C (no) 1992-12-02
NZ222214A (en) 1989-11-28
IL84203A (en) 1993-04-04
PT85949B (pt) 1990-07-31
FI874596A (fi) 1988-04-21

Similar Documents

Publication Publication Date Title
ATE70057T1 (de) Antitumormittel.
DE3775679D1 (de) Vernebler.
DE3767169D1 (de) Sportschuh.
ATE57924T1 (de) 3-aryloxy-3-substituierte-propanamine.
DE3764043D1 (de) Alkylendiamine.
ATE63533T1 (de) Xylolisomerisierung.
DE3779761D1 (de) Abseilgeraet.
DE3771918D1 (de) Chinolinamide.
DE3785294D1 (de) Neigungsmesser.
DE3786679D1 (de) Schmitt-triggerschaltung.
DE3773636D1 (de) Saeurebeschleunigte hydrocarboxilierung.
DE3771271D1 (de) Fluorphthalimide.
FI860054A0 (fi) Motionsanordning.
DE3779382D1 (de) 3-6-diphenylpyridazine.
DE3763648D1 (de) Rollski.
FI860046A0 (fi) Foerlaengningsanordning foer traefaner.
DE3766410D1 (de) Methylalkylcyclosiloxane.
DE3669032D1 (de) Okulopressionsgeraet.
DE3770459D1 (de) 3-halogensuccinimide.
DE3764485D1 (de) Polyglycidylamine.
FI860072A0 (fi) Mataranordning foer en spannmaolstork.
FI851776L (fi) Elkandelaber.
FI73944B (fi) Rullningsanordning foer pappersbana.
FI77950B (fi) Foergreningsklaemma foer en sektorformig kapad huvudledning.
FI77957B (fi) Taendnings- och matarkoppling foer lyslampor.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: NOVO NORDISK A/S